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Abstract
In order to identify novel high value antibacterial targets it is desirable to delineate whether the inactivation of the target
enzyme will lead to bacterial death or stasis. This knowledge is particularly important in slow growing organisms, like
mycobacteria, where most of the viable anti-tubercular agents are bactericidal. A bactericidal target can be identified
through the conditional deletion or inactivation of the target gene at a relatively high cell number and subsequently
following the time course of survival for the bacteria. A simple protocol to execute conditional inactivation of a gene is by
antisense expression. We have developed a mycobacteria specific IPTG inducible vector system and monitored the effect of
antisense inhibition of several known essential genes in mycobacteria by following their survival kinetics. By this method,
we could differentiate between genes whose down regulation lead to bacteriostatic or bactericidal effect. Targets for
standard anti-tubercular drugs like inhA for isoniazid, rpoB and C for rifampicin, and gyr A/B for flouroquinolones were
shown to be bactericidal. In contrast targets like FtsZ behaved in a bacteriostatic manner. Induction of antisense expression
in embB and ribosomal RNA genes, viz., rplJ and rpsL showed only a marginal growth inhibition. The specificity of the
antisense inhibition was conclusively shown in the case of auxotrophic gene ilvB. The bactericidal activity following
antisense expression of ilvB was completely reversed when the growth media was supplemented with the isoleucine,
leucine, valine and pantothenate. Additionally, under these conditions the expression of several genes in branched chain
amino acid pathway was severely suppressed indicating targeted gene inactivation.
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Introduction
Though the genome sequence of various infectious pathogens
including M. tuberculosis has been available for over a decade [1],
no new antibiotics have come to market that target a novel gene
product. Even the pharmaceutical industry pipeline in the pre-
clinical and clinical phase has only a few candidate molecules that
interact with enzyme targets identified and validated by genomic
techniques [2]. At a first glance this setback looks counterintuitive.
Literature and various bioinformatics websites are replete with
data on the essential genes of various microorganisms including
mycobacteria [3,4]. In addition to classical knockout data, we now
have various high throughput techniques like transposon muta-
genesis that have been successfully used to identify essential genes
[5,6]. Then, why is there a drought of new drugs or leads that are
based on the genomic paradigm? One of the reasons we argue is
the over reliance on essentiality as a genetic requirement for a
valid anti-infective target. Essentiality of a gene is only a necessary
genetic requirement for an anti-infective target but not a sufficient
one.
A valid anti-infective drug target is one whose inhibition leads to
the death of bacteria. However, the usual practice to establish
essentiality of a gene is to monitor growth of the bacteria in the
absence of the target gene. This is conceptually similar to the test
done for the susceptibility or the MIC (minimum inhibitory
concentration) measurement of antimicrobial agents. Under this
experimental setup both bacteriostatic and bactericidal targets
behave in a similar fashion. In order to delineate static and cidal
targets one could gradually reduce the level of target gene
expression and monitor the survival kinetics of the bacteria. This
can be done either by putting the target gene under the control of
an inducible promoter, or by gradually reducing the wild-type
gene expression by antisense inhibition. In the former, there is a
chromosomal insertion of the inducible promoter upstream of the
target gene, while in the latter case; constructs are made in
compatible plasmids such that the gene is placed in antisense
orientation under an inducible promoter. In the antisense mode,
upon induction, the expression of the gene is repressed as the
expression of the antisense RNA increases. Under saturating
expression of the antisense RNA, the target inhibition might be
equivalent to a classical knockout of the gene. Two pharmaceutical
companies, GSK and Elitra have reported the use of antisense
technology across the genome to identify essential genes in the
pathogen Staphylococcus aureus [7,8]. However bacteriostatic and
bactericidal targets were not differentiated.
In most anti-infective drug discovery cascade bactericidal effect
of a compound is rarely monitored. This practice looks minimalist
in view of the mounting evidence that in most cases bactericidal
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pointed out by Stratton, who opined for the use of bactericidal
antibiotics to counter drug resistance [9]. In addition to M.
tuberculosis, in diseases like endocarditis, clinical efficacy is found
only with bactericidal drugs. It is also argued by Levinson that for
bacteriostatic drugs to have efficacy it is necessary that it be
augmented by host defences to clear tissues of the infecting
microorganism [10]. With dysfunctional immune system the
residual pathogen resumes growth after the withdrawal of the
bacteriostatic drug and the infection relapses. As a consequence it
would seem logical to identify targets especially in mycobacteria
whose inhibition would be bactericidal. These then would be the
choicest targets for anti-tubercular drug discovery.
Since the Lac operon is absent in mycobacteria, an IPTG
inducible system was imported from E. coli as a plasmid based
system for its operation in mycobacteria. Several target genes were
cloned in the antisense orientation and the downstream effects viz.,
bactericidal or bacteriostatic, were monitored by its survival
kinetics following induction of antisense expression. Using this
technology we could delineate targets whose down regulation or
inhibition would be cidal or static for the organism.
Results
Repressor Operator Interaction
Development of a lac inducible system with a linear response
that is operational in mycobacteria requires the understanding of
the basics of repressor operator interaction. Due to the absence of
the lac operon – and more specifically the permease lacY - it could
be speculated that in mycobacteria, the inducer would enter the
cell by a diffusion-controlled fashion [11].
The semi-quantitative analysis of operator–repressor interaction
(detailed in the supporting information File S1) was used to
identify conditions that would give a minimal leaky expression
while introducing an operationally linear induction profile. Since
the parameters that could be varied are the levels of Lac I and the
number of tandem operators, we plotted f (E) as a function of these
two variables using equations 3 and 5. The values of K1 as 0.0252
(mM)
22, n as 2.09 and K as 7200 from the results of Yagil and
Yagil [12] were used in the simulation. The results (Figure 1)
indicate that with one operator we get close to linear induction and
low level of leaky expression when there is about in 5 to 25-fold
excess of LacI expression over its normal level. With multiple
operators though the basal level expression is severely repressed,
the induction becomes non-linear and the maximum induction is
not reached. We opined that using a single operator in conjunction
with a constitutive promoter of moderate strength for LacI would
result in linear induction with a negligible uninduced basal level
expression. For ease of operation, an additional feature of this
constitutive promoter should be that it is equally functional in both
the mycobacterial species, M. smegamtis and M. tuberculosis.
Construction of the lac-inducible mycobacterial vector
pAZI9018b
The inducible expression vector pAZI9018b has the following
major elements: IPTG inducible reporter gene, a constitutively
expressing LacI gene, an antibiotic marker gene and ori sequences
aiding the plasmid stability, integrity and replication in mycobac-
terial and E. coli background. For designing the inducible system,
the Lac operator was cloned downstream to the promoter and
upstream to the reporter gene LacZ. Regarding the choice of the
specific promoters that will be suitable in mycobacteria we used
Figure 1. Number of operators vs. LacI expression. Plot of fraction of free Lac operators as a function of effector concentration for different
amounts of intracellular LacI and different number of operators. Here 1X is considered to be the intracellular concentration of LacI in wild type E.coli.
doi:10.1371/journal.pone.0005923.g001
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identified by Unniraman et al. [13] as TTGACA/T(-35 region)-
17 bp spacer -TATAA/CT(-10 region)-7 bp-G/A as compared to
that of E. coli TTGACA(-35 region)-17 bp spacer -TATAAT(-10
region)-7 bp-A. It was seen that the pTrc promoter (ttgacaattaat-
cat ccggctcgtataatgtgtggAa) from the plasmid pTrc99A matched
suitably with the consensus housekeeping mycobacterial SigA
sequence. This strategy would be useful in using the vector in
future experiments under in-vivo conditions.
Regarding the constitutive lac repressor, we argued that to get a
close to linear induction profile and a low basal expression of the
target gene in mycobacteria, we needed a few fold higher
expression of Lac repressor in mycobacteria as compared to that
present in wild type E. coli. Since LacI is present in low amounts in
E. coli (,10 tetramers/cell) [14], a moderate promoter when
present in a plasmid with a low copy number (,3–4 per cell)
should be able to produce the required amount of lac repressor in
mycobacteria. Additionally it would be advantageous if the
expression level of the promoter would remain unaltered when
moved from the fast growing M. smegmatis to the slow growing M.
tuberculosis and M. bovis BCG. The T150 promoter sequence as
described by Bashyam et.al. [15] was chosen as the constitutive
promoter for the lac repressor as it was of moderate strength and
had been shown to be equipotent in both the mycobacterial
species. It had an additional advantage that its sequence
(TTGACACTTTGCGACACGCTTTTATCAT) had a high
similarity with that of mycobacterial sigA promoter ensuring that
it would be driven by the mycobacterial house-keeping sigma
factor and thus would be present nearly at all times of growth
phase. The restriction sites BamHI and NdeI in the vector are
suitably positioned so that any foreign gene could be inserted in to
the vector replacing the reporter LacZ (Figure 2).
IPTG regulated b-galactosidase activity in mycobacteria
The b-galactosidase activity of M. smegmatis harboring the vector
pAZI9018b was monitored. The assay revealed a linear increase in
the enzyme activity (mO.D.410 nm/min) over a wide range of
IPTG concentration (Figure 3). The upregulation of expression
following induction was about 30 fold. The level of leaky
expression was low as there was a fairly tight regulation at zero
IPTG concentration. The results indicated that the constitutive
promoter T150 produced enough repressor so as to block the
transcription of the lacZ gene in the absence of any inducer. It was
also observed with times of induction less than four hours the b-
galactosidase activity reduced considerably and with induction
time greater than 12 hours the fold induction reduced as there was
an accumulation of leaky expression (data not shown). The results
indicate that it took about a generation time (4-hours) in M.
smegmatis for observing the optimized effect of the IPTG induction.
It was also observed that various levels of IPTG did not have any
effect on the growth rate of the host bacteria (data not shown).
Conditional knockdown (KD) of FtsZ by antisense
expression mRNA in M. smegmatis
FtsZ protein forms a ring at the site of bacterial cell division.
Over or under production of this protein causes an imbalance in
the cell division and results in cell lysis or filamentation respectively
[16,17]. We down-regulated FtsZ gene by cloning it in antisense
orientation replacing the LacZ in pAZI9018b. Though it was the
M. tuberculosis FtsZ gene that had been cloned in antisense
orientation, it could down regulate the M. smegmatis FtsZ
expression, as there was about 92% sequence identity at the
nucleotide level. Compared to the wild type strain, the induced
antisense FtsZ strain showed a high degree of filamentation
(Figure 4). This observation is in accordance to the earlier
observation that deficiency of FtsZ causes filamentation in
mycobacteria [18], proving that the antisense mRNA was capable
of inhibiting the expression of the genomic driven FtsZ sense gene.
In order to delineate whether the downstream effect of a target
downregulation is bacteriostatic or bactericidal one has to define a
mycobacterial benchmark. This is illustrated in the generic
mycobacterial survival kinetics (Figure 5) where various zones
have been defined. Though, the standard 99.9% kill is defined as
bactericidal for antibiotics, the slow growth of M. tuberculosis brings
in an element of time dependence while evaluating cidality and
stasis. From the survival kinetics of FtsZ antisense strain it was seen
that the target behaved in a bacteriostatic fashion. There was a
meagre drop of 1.5 log10 in cfu at an inducer concentration of
10 mM IPTG (Figure 6). There was no further reduction in cfu at
higher IPTG concentration.
Conditional KD of gyrA and gyrBi nM. smegmatis and M.
tuberculosis
Gyrase is an essential enzyme containing two subunits encoded
by the genes gyrA and gyrB. It is the target of the bactericidal
antibiotics belonging to the class of quinolones and coumarins that
bind to gyrA and gyrB respectively. Its essentiality is derived from
the fact that it is the only enzyme that is able to introduce negative
supercoils into DNA which is critical in cellular processes like
replication, recombination and transcription that depend on the
unwinding of DNA strands.
Full-length antisense genes of gyrA and gyrB were cloned into
pAZI9018b and transformed into M. smegmatis and the survival
kinetics following the antisense induction of the individual genes
monitored. The results (Figure 7) indicate that while induction of
antisense of gyrA resulted in more that 3-log10 reduction of the
bacteria, the induction of antisense of gyrB was well tolerated and
the bacteria grew normally. This data looked contradictory at the
outset. However during the literature search it was seen that a
gene designated as orphan gyrB was identified in M. smegmatis [19].
We speculated that while the wild type gyrB expression is reduced
the orphan gyrB was capable in taking over the activity and thus
preventing cell death. In order to prove this hypothesis we
transformed the same constructs in M. tuberculosis and monitored
the survival kinetics. The global analysis of M. tuberculosis genome
did not indicate the presence of any additional putative gyrB; also
the tranposon mutagens data indicated that both these genes were
essential in M. tuberculosis [6]. The survival kinetics data (Figure 8)
indicate that contrary to M. smegmatis, induction of antisense of
both gyrA and gyrBi nM. tuberculosis resulted in greater than 3 log10
reduction in cfu. Thus, validating our general hypothesis that both
gyrA and gyrB were indeed bactericidal targets. Interestingly the kill
kinetics of moxifloxacin even at its MBC of 1 ug/ml, is much rapid
than the gyrase antisense (Figure 8). This probably is due to the
fact that the drug not only inactivates gyrase, but also traps the
enzyme DNA complex setting up a down stream complex cascade
resulting in generation of oxidative stress leading to a faster cell
death-a process that is probably not initiated in the simple
downregulation or inhibition of gyrase.
Conditional KD of inhA, embB, rpoB, rpoC, rplJ and rpsL
The standard antitubercular therapy includes frontline drug
such as isoniazid, rifampicin and ethambutol, which targets the
genes inhA, rpoB subunit of RNA polymerase and embB. In
addition to Streptomycin, the antibiotic Linezolid and some
modified macrolides has shown promise and may become a part
of second line anti-tubercular therapy. These molecules elicit
their antibiotic response by binding to 30 S and 50 S ribosomal
Static and Cidal Targets
PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5923Figure 2. Construction of pAZI9018b (10767 bp). The genes for selection marker hygromycin, the origins of replication for E. coli (OriE) and
mycobacteria (OriM) were taken from pSMT3 a shuttle vector. Reporter gene LacZ and the rrnB terminators were taken from a plasmid pEU720.
Constitutive LacI, mycobacterial SigA promoter and lac operator genes were derived from pTrc99A. This inducible vector has 7 elements: 1) LacZ
reporter gene, 2) pTrc promoter, 3) Lac operator, 4) Constitutive LacI,5 )E.coli origin of replication, 6) Hygromycin B Kinase, the selection marker, 7)
pAL5000 origin- mycobacterial origin of replication genes.
doi:10.1371/journal.pone.0005923.g002
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(rifampicin, isoniazid, ethambutol and streptomycin) elicit their
efficacy by inhibiting the enzyme in-vivo or is a result of some
unknown feature of the compounds, full-length genes rpoB, rpoC,
inhA, embB, rplJa n drpsL were cloned in antisense in the vector
pAZI9018b.
The resulting transformants were monitored by survival kinetics
following induction. The results indicate that the knockdown of
the genes inhA, rpoB and rpoC resulted in a gradual death of the
bacteria indicating that these targets were indeed bactericidal and
in line with our current thinking about their worth as validated
anti-tubercular targets (Figure 9). In contrast, down regulation of
embB only shows a minor growth inhibition compared to the wild
type (Figure 10). These results are not surprising. Although the
molecular basis of action of the pro-drug isoniazid is complex, it is
proven that inhA is its primary target [20]. It could also be argued
that through the inhibition of inhA, in addition to inhibition of
mycolic acid biosynthesis it could also alter the NAD+/NADH
ratio, which is a signal of cellular death. Recent results indicate
that compounds that directly inhibit inhA are also efficacious [21].
Thus we have a strong evidence that knockdown of inhA could be
bactericidal. The antisense inhibition of rpoB and rpoCi nM.
smegmatis causes rapid cidality (Figure 9). A similar picture was also
observed in M. tuberculosis (data not shown.). In contrast the
connection between embB and ethambutol is being questioned.
Recent clinical data indicate a lack of correlation between embB
mutation and Ethambutol MIC in M. tuberculosis [22]. In addition
it is seen that although the genes embA and embB are essential in M.
tuberculosis, the deletion of these genes is viable in M. smegmatis
although the growth rate is affected [23]. Our experiment
evaluates the survival of M. smegmatis following the expression of
embB antisense, and the results are in accordance to the embB
knockout characteristics [23]. The down regulation of the
ribosomal genes rplJ and rpsL also did not elicit any major growth
modulation; the survival kinetics indicated that it could be
classified as ‘‘barely bacteriostatic’’ (Figure 10). This result is in
consonance with the recent finding that of the several classes of
antibiotics that target the ribosome only the aminoglycosides,
kanamycin and gentamycin are bactericidal as it induces
mistranslation and misfolding of membrane proteins resulting in
generation of oxidative stress the causative agent for cidality [24].
In contrast, antibiotics like spectinomycin (ribosome inhibitors) are
bacteriostatic as it only prevents translation step (and does not
induce mistranslation) effectively analogous to the antisense
expression of rplJ and rpsL construct.
Specificity of antisense inhibition: Reversible KD of ilvB
Though antisense effect shows profound effect with some genes,
the question might remain on the specificity of antisense driven
survival kinetics. The simplest way to test specificity of antisense
effect is to monitor the survival kinetics of a known auxotropic
target. The gene ilvB (Rv3003c) is involved in the synthesis of
branched chain amino acids, isoleucine, leucine and valine and
also pantothenate. The gene is essential when the bacterium grows
in minimal media, which is not the case when grown in presence of
the aminoacids and pantothenate. The survival kinetics (Figure 11)
of antisense of ilvB in absence and presence of amino acids shows
that the antisense effect can be completely reversed in presence of
the amino acids. This result clearly indicates the specificity of gene
knockdown by antisense expression. In order to characterize the
behaviour of the local transcriptome following the antisense
expression of ilvB, qRTPCR of the genes in the branched amino
acid pathway was carried out. The results indicate that as
predicted the entire pathway was down regulated (Table 1), thus
Figure 3. Validation of the inducible promoter system by b-galactosidase assay. Mycobacterium smegmatis mc
2155 cultures harboring the
plasmid pAZI 9018b were induced in triplicate with IPTG in a dose dependent manner (0,1,10,100,1000 mM). The b-galactosidase activity was
monitored at O.D.410 in SpectraMax Plus
384 spectrophotometer at 37uC after adding ONPG.
doi:10.1371/journal.pone.0005923.g003
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Though the antisense was targeted against ilvB gene, only 2-fold
downregulation of the ilvB, ilvN and ilvC transcripts were seen.
These three genes are in an operon and form a polycistronic
message. In contrast the other genes in the pathway were down
regulated to a larger extent. This apparent variation was clarified
by the observation that by using thermostable reverse transcriptase
in the RTPCR we were capturing both the mRNA and the
mRNA-antisense hybrid (data not shown). The transcriptional
attenuation of ilv regulon in prokaryotes is a concerted
phenomenon [25]. Hence we have the down regulation of entire
pathway following antisense inhibition.
Discussion
Discerning whether an in-vivo inhibition of a target enzyme
would lead to downstream growth characteristics that range from
bactericidal to bacteriostatic to ineffective has always been
evaluated by compounds that specifically inhibit the target
enzyme. However for novel target driven anti-infective drug
discovery, the paucity of this relevant information leads to an
expensive alternative in evaluating the target through high
throughput screening (HTS). However the success in this process
as measured by identification lead molecules that kill the bacteria
through specific mechanism of action is minimal [2]. We have
Figure 4. FtsZ antisense expression in mycobacteria. Microscopic (1000x) observation of M. tuberculosis FtsZ antisense construct in M.
smegmatis mc
2155: M. smegmatis mc
2155 transformed with Mtu FtsZ antisense (AS) construct. The colonies appeared after 8 days (vs.control in 3
days) & showed poor growth in broth (inhibited). Culture concentrated to normalize the cell number (vs. WT) for induction with IPTG. Panel A. M.
smegmatis mc
2155 host (WT) and Panel B. M. smegmatis mc
2155 with Mtu FtsZ antisense gene, both induced for 48 hrs. with 1 mM IPTG. The
induced cultures of FtsZ antisense clone (Panel B) showed filamentation with elongated cells (no septation), as observed under phase contrast
conditions in 1000X. Micrographs were taken using AxioVision Rel. 4.5 software.
doi:10.1371/journal.pone.0005923.g004
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to characterize novel targets. One of the key assumptions of this
exercise is that specific in-vivo inhibition of a target enzyme by its
inhibitor is equivalent to down regulation of the target enzyme by
antisense expression. This assumption is logically tenable as a 50
% inhibition of enzyme activity can be thought either as a case
where 50% of the enzyme molecules are fully active while the rest
is inactive to the alternative where every molecule is active only
half the time. The former simulates the case of inhibition by an
irreversible inhibitor while the later is similar to the case of
reversible one. In our current model of specific antisense
expression, it is the number of active enzyme molecules that are
reduced and hence the growth characteristics as monitored by
survival kinetics would simulate an effective compound inhibiting
the target enzyme.
Inducible systems are powerful tools for studying gene function
and for the validation of drug targets in bacteria. However few
regulated systems are available for mycobacterium gene expression
[26,17,27]. The characteristics governing an ideal inducible
promoter system are- 1: there should be little or no expression
of the target gene in the absence of an inducer, 2: the strength of
the promoter should be moderate enough to give an appreciable
window within the working range of the inducer, 3: the non-
metabolizable inducer should not be required to be present at
toxic levels, 4: it should regulate in a dose dependent manner, 5: in
case of the studies in an intracellular pathogen, it should allow the
regulatable expression under in-vivo conditions. However, the
crucial feature of an inducible system should be that the inducer
enters the bacteria by diffusion-controlled mechanism. For inducer
entering the cell via active transport there is an ‘‘all or none’’
phenomenon. Thus at sub-saturating concentration of the inducer,
some cells are fully induced while majority remains uninduced
[11]. Under this scenario it would be difficult to interpret survival
kinetics. The linearity of induction as exemplified in the b-
galactosidase assay provides a clue that in mycobacteria, IPTG
enters the cell via passive diffusion.
Our results broadly suffice the above-mentioned characteristics.
We have also seen the possibility of system to operate when the
bacteria is present in intercellular conditions, (data not shown). In
order to achieve an ideal expression system described above for
mycobacteria, we have used SigA dependent promoters that
operate under normal growth conditions. Using the consensus
SigA motif as predicted by Unniraman et al. [13] we showed that
the well-studied E. coli pTrc promoter was also effective in
mycobacterium. The control of inducible expression is a direct
interplay between the repressor concentration, effector concentra-
tion and the binding constant of the operator. This interplay had
been modeled by Yagil and Yagil [12]. We have used the simple
time independent formulation to simulate a condition that gives a
linear dose response. It is seen that for a given pair of repressor
and operator there are multiple ways to alter the nature of dose
response. To tighten the control one could increase the
concentration of the repressor or increase the number of operator
molecules upstream of the gene. As described earlier we have used
Figure 5. Bacteriostatic and bactericidal target zones. Generic survival kinetics on delineating bactericidal and bacteriostatic targets. The
zones differentiating cidality, stasis and no effect are indicated.
doi:10.1371/journal.pone.0005923.g005
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express sufficient LacI that gives a linear dose response with tight
control. However compared to the induction profile of protein
expression as in case of b-galactosidase where we have an excellent
window of expression, the dose dependence for survival kinetics
with antisense expression has a much smaller window (data not
shown). In case of former the induction time is four hours whereas
the time for monitoring survival kinetics is in days. The lack of a
Figure 7. Survival kinetics of M. smegmatis (with M. tuberculosis gyrA-AS and gyrB –AS plasmids individually). Induction at 10 uM IPTG
concentration. In the case of gyrA-AS r-M. smegmatis the cfu reduction is .3 log10 (bactericidal target), but gyrB-AS showed no cfu reduction as the
orphan gyrB takes over once the other gyrB transcript is blocked.
doi:10.1371/journal.pone.0005923.g007
Figure 6. Survival kinetics of M.smegmatis (harbouring M. tuberculosis FtsZ-AS plasmid). Induction at 1 uM IPTG of the FtsZ r-M. smegmatis
shows ,1.5 log10 cfu reduction, categorizing it as a bacteriostatic target.
doi:10.1371/journal.pone.0005923.g006
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understood in light of product accumulation. The antisense RNA
expression in absence of inducer, which is negligible in a four-hour
time span, might become significant when the induction time is in
days due to accumulation of product. This has been observed with
b2galactosidase expression. It could be similar with antisense
expression.
The antisense induction of various targets for standard anti-
tubercular drugs like inhA for isoniazid, rpoB and C for rifampicin,
and gyrA/B for flouroquinolones were shown to be bactericidal. In
contrast targets like FtsZ showed only a moderate growth
inhibition. That the targets inhA and embB differed so dramatically
in their survival kinetics is probably explained by their contrasting
essentiality in M. smegmatis. We have also monitored antisense inhA
survival kinetics in M. tuberculosis. The results indicate that the
target is in the bactericidal zone (data not shown). The antisense
expression of ribosomal RNA genes like rplJ and rpsL produced
‘‘barely bacteriostatic’’ effect. This is probably due to long half-life
of the ribosome and the fact that antibiotics that target ribosome
affect protein folding rather than ribosome recycling [28].
Additionally it has been recently shown that among the antibiotics
that target ribosome, aminoglycosides like kanamycin and
gentamycin are bactericidal because they induce membrane
proteins to mistranslate and hence misfold in the periplasmic
space leading to generation of free radicals [24]. In contrast, some
ribosome inhibitors like spectinomycin are bacteriostatic, as they
do not initiate mistranslation. It would thus be logical to speculate
that antisense rplJ and rpsL function as simple ribosome inhibitors
and thus do not induce cidality. Additionally it should also be
noted that compared to mRNA, ribosomal RNA are much more
stable and has a longer half life [29]. It is also structurally more
robust than mRNA and its concentration is also higher than a
specific mRNA. All of these factors adding up and blunting the
effect of antisense rplJ and rpsL.
Of these, the results for gyrBi nM. smegmatis in a way validate the
whole approach. While designing the experiment we had
inadvertently assumed gyrB to be essential in M. smegmatis.
However when the results indicated that antisense of gyrB did
not show any bactericidal effect in its survival kinetics we realized
the presence of an orphan gyrB earlier identified [19]. In order to
prove the validity of this argument we did evaluate the survival
kinetics of antisense gyrA and gyrBi nM. tuberculosis. The result
indicated that the down regulation of both these genes were
bactericidal as there were no homologs of the gyrase genes present
in this species. It is also seen that moxifloxacin induced killing is
faster than gyrase antisense, thus indicating the possibility with
flouroquinolones the inhibition of gyrase is complex and the
mechanism of cell death is mainly related due to its downstream
effects, a fact that is well known [30,31].
That these results were specific for the genes concerned and not
due to any off target effect were further validated by the survival
kinetics of ilvB antisense expression. The bactericidal effect was
Figure 8. Survival kinetics of M. tuberculosis (with M. tuberculosis gyrA-AS and gyrB-AS plasmids individually). Induction at 10 uM IPTG.
gyrA-AS is bactericidal whereas gyrB-AS is showing no-effect due to an extra copy of gyrB gene (orphan gyrB). Survival kinetics of wild type M.
tuberculosis upon exposure to 1 ug/ml conc. of Moxifloxacin is cidal.
doi:10.1371/journal.pone.0005923.g008
Static and Cidal Targets
PLoS ONE | www.plosone.org 9 June 2009 | Volume 4 | Issue 6 | e5923Figure 9. Survival kinetics of M.smegmatis (with M. tuberculosis inhA-AS plasmids individually). Induction at 10 uM IPTG concentration.
InhA-AS shows .3 log10 (bactericidal target) cfu reduction in M. smegmatis.
doi:10.1371/journal.pone.0005923.g009
Figure 10. Survival kinetics of M. smegmatis (with M. tuberculosis embB-AS, rpsL-AS & rplJ-AS plasmids). Inducing at 10 uM IPTG
concentration. All of these antisense genes show a lesser growth rate as compared to the control, thus are bacteriostatic targets.
doi:10.1371/journal.pone.0005923.g010
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pantothenate indicated the specificity of antisense induction. It was
also seen that following ilvB antisense expression, the branched
chain amino acid biosynthesis transcriptome was specifically down
regulated.
It is becoming gradually accepted that bactericidal drug targets
are better targets for anti-mycobacterial drug discovery. It has
recently been demonstrated that at least in E. coli and S. aureus,
bactericidal action of antibiotics is due to the induction of hydroxyl
radicals,whilebacteriostaticantibioticsdonotproducethem[31].If
this method of cellular death is true in case of slowly growing
mycobacteria then it would be interesting to see whether
knockdown of bactericidal targets also produce the same radicals.
However generalization across species might sometimes be fraught
with the danger of oversimplification. The antibiotic Rifampicin,
which is bactericidal in M. tuberculosis, is bacteriostatic in E. coli [31].
We feel that the present technology will aid in identifying novel
targets for M. tuberculosis whose inhibition would lead to the death of
the bacteria. Finally one of the interesting points raised by these
experiments concerns the value of using M. smegmatis as a model
system for M. tuberculosis. It seems that for genes, which are present
asasingle copyinboththeorganisms,and forpathwayswherethere
is a one to one correspondence, the answers to biological question
will be qualitatively similar. It might also be appreciated that if the
time axis of the survival kinetics is normalized to number of
generations instead of number of days, both the mycobacterium
species behave in a somewhat similar fashion.
One of the major factors that drive the consistency of antisense
expression in slow growing mycobacteria is the stability of the
shuttle vector under induced conditions for at least eight weeks.
We had tested the stability of the plasmid by growing the bacteria
in absence of Hygromycin and measuring colony forming units
(cfu’s) in presence and absence of the antibiotic marker. The
results indicate (data not shown) that the plasmid pAZI9018b was
stable during the period of induction.
Figure 11. Survival kinetics of M. tuberculosis (with M. tuberculosis ilvB-AS plasmid). Induction at 10 uM IPTG concentration. The
transformants grown in the in the absence of the supplements showed a strong antisense effect with .3 log10 cfu reduction (bactericidal target).
This effect was reversed when grown in the presence of supplements (isoleucine, leucine, valine and pantothenate).
doi:10.1371/journal.pone.0005923.g011
Table 1. Fold down regulation of genes in the branched
chain amino-acid pathway in the ilvB antisense M. tuberculosis
strain.
Gene Mean StDev
ilvB 20 . 3
ilvA 4.76 1.04
ilvC 2.21 0.4
ilvD 12.12 1.94
ilvE 14.66 1.97
ilvG 24.52 2.06
ilvN 2 0.31
LeuA 7.69 1.33
LeuB 39.36 4.21
rpoB 1.02 0.02
doi:10.1371/journal.pone.0005923.t001
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Bacterial strains, media, competent cells and
transformations
E. coli MOS Blue cells {F’endA1 hsdR17 (rK
2 mK
+), supE44 thi-
1 recA1 gyrA96 relA1 lac [F’ lacI
qZDM15 proAB
+ Tn10 (Tet
R)]}
(Amersham) were used for general cloning and propagation host.
E. coli Able K {E. coli C lac (LacZv
–)[ K a n
r McrA
– McrCB
–
McrF
– Mrr
– HsdR( r K
2mK
2)] [F’ proAB lacI
qZDM15 Tn10
(Tet
r)]} (Table 2) from Stratagene replaced E. coli MOS Blue
cells as the propagation host for pAZI9018b plasmid; as the use
of this strain reduces the copy number by ,10 times which to a
large extent alleviates the problem of plasmid instability.
Electrocompetent E. coli cells were prepared by growing the
cells in SOB medium to an O.D.600 nm of 0.7–0.8, chilled on ice,
centrifuged at 1500 6g, thrice washed with equal culture
volume chilled 10% glycerol, resuspended in 10% glycerol to
a final O.D.600 nm=100, flash frozen in dry ice and stored at
270uC.
Mycobacterium smegmatis mc
2155 was maintained in 7H9 broth
(DIFCO) +0.15% Tween or 7H11 agar (DIFCO) supplemented
with OADC. Similar conditions were maintained for slow growing
mycobacteria M. tuberculosis H37Rv ATCC 27294. Cells were
grown in the above medium and competent cells were prepared
similar to E. coli MOS Blue cells with the variation that washing
and suspension of the cells were done in 10% glycerol with 0.1%
Tween. Three different independent transformations were per-
formed. Transformations in E. coli, Mycobacterium smegmatis mc
2155,
and M. tuberculosis H37Rv ATCC 27294 were done at 4uC with
common settings of 25 mF, 1000 V and 2.5 kV in 0.2 cm cuvette
in a BIO-RAD Gene-PulserH II electroporation unit. After
pulsing, cells were resuspended in prewarmed respective media
and recovered for two-generation times before plating on selective
medium. Hygromycin (Roche) was always used at a concentration
of 50 mg/ml. The plates were incubated for ,30 generation time
for each species. The transformants were picked up from the
triplicate transformations in 7H9 broth (with supplements)
containing 50 ug/ml hygromycin for mycobacteria and in LB in
case of E. coli. The O.D.600 nm was adjusted to ,0.1 and incubated
for 24 hrs at 37uC. The cells were divided into 5 different aliquots
and induced at 0, 1, 10, 100 and 1000 mM IPTG. The antisense
effect was estimated by plating for the cfu enumeration on
different generation times (M. smegmatis: Day 0, 1, 3, 5, 7 and for
M. tuberculosis: Day 0, 1, 7, 14, 21, upto 63 days with a gap of 1
week).
Plasmids and Enzymes
pSMT3 is a shuttle vector with E. coli pMB1 origin of
replication (relaxed replication), a hygromycin resistance gene
and the mycobacterial pAL5000 origin of replication (stringent
replication with a copy number of 3–4). pEU720 [32] contained a
promoterless LacZ gene flanked by multiple rrnB terminators. LacI
gene was derived from pTrc99A (Pharmacia). DNA polymerase
Phusion (Finnzymes) was used in all amplification reactions
according to manufacturer’s instructions supplemented with
DMSO and Betaine. Other enzymes were either from NEB or
Amersham Biosciences.
Cloning of pAZI 9018b
The cloning was strategized (Figure 2) in a way so as to
minimize the number of steps required and also to optimize the
size of the final vector which would contain the following seven
elements: 1) LacZ as the reporter gene, 2) a mycobacterial sigA
promoter to drive this gene, 3) a lac operator controlling this
promoter, 4) LacI gene driven by a constitutive mycobacterial
(sigA) promoter, 5) E. coli origin of replication, 6) mycobacterial
origin of replication and 7) hygromycin resistance gene. Constructs
at different stages were named according to the elements present
on them.
DNA fragment strictly encompassing the three elements OriE,
OriM and hygromycin resistance gene [33] was amplified from
pSMT3 using primers HYGR and MORR (Table 3), gel purified,
digested with NheI and DpnI, ligated and transformed in E. coli to
get the plasmid p567. Next step was to insert the promoter-less
reporter gene LacZ flanked by multiple transcriptional terminators
so as to minimize any non-specific transcription. This fragment
was amplified from pEU720 using primers PTLF2 and PTLR3
ApaI, gel purified, digested with MfeI and ApaI and ligated to MfeI
and ApaI digested p567, followed by transformation in E. coli to get
the plasmid p1567’. However, the pSMT3-derived fragment
carried a pHsp60 promoter between OriE and OriM. To delete this
region p1567’ was digested with NotI and MscI, completely filled in
using Klenow (Exonuclease free), self-ligated and transformed in
E. coli to get p1567.
Next step was to insert a promoter with a lac operator upstream
of the LacZ. However, insertion of such a fragment in p1567 (see
p123567 in Figure 2) in absence of any lac repressor resulted in
severe plasmid instability and severe cell growth inhibition in E.
coli MOS Blue, probably due to very high constitutive expression
of LacZ. Thus we decided to introduce a constitutive Lac repressor
along with. This fragment, which would incorporate a LacI gene
Table 2. Bacterial strains and plasmids used in this study.
Strains Description Source or Reference
E. coli DH5a Competent cells AZI Collection
E. coli pMOS Blue Competent cells Amersham Biosciences
E. coli AbleK Competent cells Stratagene
M. smegmatis mc
2 155 Gene expression and survival kinetics studies AZI collection
M. tuberculosis H37Rv
ATCC 27294
Gene expression and survival kinetics studies ATCC
Plasmids Description Source or Reference
pSMT3 E. coli-mycobacterial shuttle vector Kindly provided by Dr. Neil Stoker, London School of Tropical Medicine and Hygiene,UK.
pEU720 for b-galactosidase gene Kindly provided by Dr. Scott, Emory University
7
pTrc 99A for pTrc Promoter Pharmacia
doi:10.1371/journal.pone.0005923.t002
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with a lac operator upstream of LacZ, was amplified from pTrc99A
using primers PTRCLACOREV and LACIPT150, digested with
EcoRI and HindIII and ligated to purified MfeI and HindIII digested
p1567 and transformed in E. coli ABLE K (Stratagene). The
resulting transformants were stable. The final vector was
designated as pAZI9018b.
Validation of the inducible promoter system by b-
galactosidase assay
The plasmid pAZI 9018b (Figure 3) was transformed into E. coli
ABLE K for propagation and M. smegmatis mc
2 155 for the b-
galactosidase activity assay respectively. The M. smegmatis colonies
were grown in 7H9 selective media containing hygromycin at
50 mg/ml concentration. Upon reaching an O.D.600 nm=0.6,
each set of culture was divided into 7 in a 24 well plate and were
induced with 0, 1, 10, 100, and 1000 mM of IPTG (Sigma)
respectively for 4 h at 37uC (for M. smegmatis). 500 ml of each
induced culture was then lysed on ice by two 30-second cycles of
sonication at 15 seconds interval. The b-galactosidase assay was
done with 40 ml of lysate in 260 ml of the Z buffer [0.06 M
Na2HPO4.7H2O, 0.04 M NaH2PO4.H2O, 0.01 M KCl, 0.001 M
MgSO4, 0.05 M b-mercaptoethanol, pH 7.0 containing 1 mg/ml
of ONPG as substrate at 37uC and the O.D.410 nm was monitored
using Spectramax (Molecular Devices, SpectraMax Plus
384
spectrophotometer). The assay was done in triplicate and each
experiment was repeated at least twice.
Validation of inducible system by antisense inhibition of
essential genes FtsZ, gyrA, gyrB, rpoB, rpoC, inhA, embB,
rpsL and rplJ from M. tuberculosis in M. smegmatis
Full-length M. tuberculosis FtsZ, gyrA, gyrB, rpoB, rpoC, inhA, embB,
rpsL and rplJ genes were PCR amplified from genomic DNA using
the forward and reverse primers (FtsZR, FtsZF, gyrAR, gyrAF,
gyrBR, gyrBF, rpoBR, rpoBF, rpoCF, rpoCR, inhAR, inhAF, embBF,
embBR, rpsLF, rpsLR, rplJF and rplJR) and cloned into NdeI and
BamHI (or XbaI) sites of the vector pAZI9018b. These constructs
(FtsZ-pAZI 9019, gyrA-pAZI 9400, gyrB-pAZI 9401, rpoB-pAZI
9402, rpoC-pAZI 9403, inhA-pAZI 9404, embB-pAZI 9435, rpsL-
pAZI 9436 and rplJ-pAZI9437) that had the target genes in the
antisense orientation were transformed into M. smegmatis compe-
tent cells by electroporation. The colonies were picked up and the
cultures were grown in 7H9 broth. The growth was very slow. For
the induction experiment, the culture had to be concentrated to
match the O.D.600 nm of the control culture. The cells were
allowed to undergo four generations in the induced form. In the
case of FtsZ culture, the morphology was examined by light
microscopy (1000X) under phase contrast conditions (Figure 4).
Validation of inducible system by antisense inhibition of
essential genes: M. tuberculosis gyrA and gyrBi nM.
tuberculosis
The antisense constructs of full length gyrA, gyrB, and inhA genes
were transformed in M. tuberculosis competent cells at room
temperature with the similar BIORAD electroporator settings as
for M. smegmatis. The transformants were picked up from the
triplicate transformations in 7H9 broth (with supplements)
containing 50 ug/ml hygromycin. The O.D.600 nm was adjusted
to ,0.1 and incubated for 24 hrs at 37uC. The cells were divided
and induced at 0, 1, 10, 100 and 1000 mM IPTG. The effect of
antisense was measured by plating for the cfu enumeration on
different days. All experiments pertaining to M. tuberculosis were in
triplicate, whereas those with M. smegmatis are repeated twice.
Specificity of anti-sense inhibition: Reversible survival
kinetics of ilvB
Full-length M. tuberculosis ilvB gene was PCR amplified from
genomic DNA using the forward and reverse primers and cloned
into NdeI and BamHI site of the vector pAZI9018b. The construct
(ilvB-pAZI9406) that had the target gene in the antisense
orientation was transformed into M. tuberculosis competent cells
by electroporation.
The transformants were picked up and O.D.600 nm was adjusted
to 0.1 with approximately 10
7 cells/ml. These were grown in the
presence and absence of ilv20 (isoleucine, leucine and valine, each
@ 20 ug/ml conc. and pantothenate @ 50 ug/ml conc.). The cfu
enumeration was performed on 1, 3, 5, 7, 14 and weekly upto
about 63 days; in the presence and absence of IPTG (inducer @
10 uM conc.). The survivors’ cfus were plotted against the number
of days.
Branched chain amino acid transcriptome analysis
following antisense expression of ilvB gene in M.
tuberculosis
M. tuberculosis cells containing ilvB antisense plasmid were grown
as log phase culture in the presence of ilvP (isoleucine, leucine and
valine, each at 20 ug/ml conc. and pantothenate at 50 ug/ml
conc. The inducer IPTG was at 100 uM conc.). Wild type (WT)
M. tuberculosis culture was also grown in a parallel log phase culture
without the supplements. One ml of TrizolH was added to the cell
pellets (from 5 ml culture) to stabilize and arrest the mRNA. Cells
were disrupted by bead beating using 0.1 mm diameter zirconium
beads (Biospec), followed by a 5 min centrifugation at 14,000 g.
Total RNA was isolated by chloroform treatment and precipitated
by using isopropanol and centrifuged 14,000 g for 20 min. The
RNA pellet was washed with 70% ethanol, repelleted at 14,000 g
for 10 min. RNA samples were further treated by DNAse I
treatment (Ambion Cat# 2222-DNAse) for 30 min. at 37uCt o
remove any residual DNA contamination. The sample was then
purified using RNEasy mini kit, Qiagen).
RNA concentration was estimated using nanodrop spectropho-
tometer. An aliquot 100 ng of RNA was used for each WT and
ilvB antisense recombinant Mtu for cDNA synthesis and RTPCR.
A total of 11 genes were selected from the branched chain amino
acid pathway to see the after effect of ilvB gene down regulation on
Table 3. Primers used in the present study.
Primer Sequence (59-39)
HYGR CATGCTAGCTCAGGCGCCGGGGGCGGTGT
MORR CATGCTAGCTAGAACAGCGGTGGATTGTC
PTLF2 CATCAATTGCGTCTTCAAGAATTAATTCCCAA
PTLR3APAI CATGGGCCCCGCTGCCCGACTGCTTTC
LACO5A AGCTATGTTGACATTTTTTTCAATATTTGTTATAATGTGTGGGGAATTGT
GAGCGGATAACAATTCCCCTGCA
LACIPT150 CATAAGCTTGAATTCTTGACACTTTGCGACACGCTTTTATCATTTTCC
GACATATAAGAAGGAGGATTCAGGGTGGTGAATGTGA
Ptrclaco
rev
CATAAGCTTTCCTGTGTGAAATTGTT
FtsZR ATTCCAACATATGATGACCCCC CCGCACAACTA
FtszF AGGCCTAGGATCCTCAGCGGCGCATGAAGGGCG
doi:10.1371/journal.pone.0005923.t002
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as the house-keeping gene. RTPCR was performed in quadrupli-
cate using Qiagen (single tube) RTPCR kit using SYBR Green
chemistry. Real-time PCR (Mx3000P Stratagene) conditions
include initial denaturation at 95uC for 15 min, followed by 40
cycles of denaturation at 94uC for 30 sec, annealing and extension
at 59uC for 30 sec. Reverse and forward primers used are listed
below in Table 4. The fold down regulation of the expression of
the genes in the ilvB antisense strain was calculated using the
equations described below. The normalization factor, i.e. the level
of expression of a gene compared to rpoB was first estimated in the
WT cells.
Normalization factor, NgeneX ~ 2DCtn ð1Þ
Where DCtn~ Ct ðÞ rpoB{ Ct ðÞ geneX
Ct defined as the threshold cycle for each gene. The fold down
regulation, FgeneX for each gene in the ilvB antisense strain was
then calculated using the equation
FgeneX ~ CtA ðÞ geneX { CtA ðÞ rpoB
hi .
NgeneX ð2Þ
Where CtA is the corresponding threshold cycle of the gene in the
antisense strain.
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